Skip to content
Screener

MBX Biosciences, Inc. MBX Price / book

Price / book at other companies

Eli Lilly logo
Eli LillyLLY
31.6×-6.7×
Amgen logo
AmgenAMGN
16.7×-3.4×
Viking Therapeutics logo
Viking TherapeuticsVKTX
7.5×+4.3×
Amylyx Pharmaceuticals, Inc. logo
Amylyx Pharmaceuticals, Inc.AMLX
8.3×+4.9×
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
4.6×+2.9×
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
4.7×+0.8×

Other financials

Income statement

See full
Operating income-$27.3M-2.8%
Net income-$23.5M+1.5%
EPS (diluted)-$0.50+29.6%

Balance sheet

See full
Cash & equivalents$45.2M+51.2%
Total debt$555.0K+327%
Total equity$437.8M+85.9%
Total assets$452.7M+84.1%

Cash flow

See full
Operating cash flow-$20.2M+10.9%
CapEx$437.0K+1,357%
Free cash flow-$20.6M+9.1%

Valuation

See full
Market cap$3.19B+719%
Enterprise value$3.15B+798%

Returns & leverage

See full
Return on equity-25.7%—
Debt / equity0×0.0×
Current ratio30.8×+7.5×

Where this comes from

Calculated from MBX Biosciences, Inc.’s reported figures.

market cap/total stockholders equity=3.2×

Based on the most recent quarter.

The source filing: MBX Biosciences, Inc.’s 10-Q, filed May 7, 2026. Open the filing →

Filed
May 7, 2026, 9:03 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-210593

FAQ

What is MBX Biosciences, Inc.'s price / book?
MBX Biosciences, Inc. (MBX) reported price / book of 3.2× in Q1 2026.
How has MBX Biosciences, Inc.'s price / book changed year-over-year?
MBX Biosciences, Inc.'s price / book increased by 209.2% year-over-year, from 1× to 3.2×.
What does price / book mean?
Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.

Ask your AI about MBX Biosciences, Inc.'s price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude